ISIRV and ECDC influenza epidemiology meeting 16-18 January 2019
The ISIRV (International Society for Influenza and other Respiratory Virus Diseases) Epidemiology Group and ECDC are holding an influenza epidemiology meeting at ECDC in Stockholm 16-18 January 2019.
Influenza vaccination coverage rates insufficient across EU Member States
None of the European Union (EU) Member States could demonstrate that they reach the EU target of 75% influenza vaccination coverage for vulnerable groups, according to a new report from the European Centre for Disease Prevention and Control (ECDC).
Flu Awareness Week, 22 – 26 October 2018
The Flu Awareness Week is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
The sleeping giant: the danger of neglecting latent tuberculosis infection
The European Centre for Disease Prevention and Control (ECDC) has published comprehensive guidance on the management of latent tuberculosis infection (LTBI) targeted for European Union/European Economic Area (EU/EEA) countries.
Reaching the SDG targets on Health by 2030: ECDC Session at European Health Forum Gastein 2018
Will we reach the United Nations Sustainable Development Goal (SDG) for health by 2030 and the targets set for HIV/AIDS, hepatitis and tuberculosis? ECDC’s session at the European Health Forum Gastein looks at the action required to end AIDS and TB, and to combat hepatitis.
Updated European Union Standards for Tuberculosis Care now available
The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) have developed 21 patient-centred standards to guide clinicians and public health workers in their work to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe.
Epidemiological update - Increase in Echovirus 30 detections in Denmark, Germany, the Netherlands, Norway and Sweden, June to July 2018
In 2018, Norway  and the Netherlands  published reports from national public health institutes on increased Echovirus 30 (E30) detections associated with an increase in the number of meningitis or meningoencephalitis cases. Since the beginning of 2018, 407 E30 cases have been reported to ECDC in 10 EU/EEA countries based on an Epidemic Intelligence Information System–Vaccine Preventable Diseases (EPIS-VPD) data call.
New case of MERS-CoV identified in the United Kingdom
A new case of Middle East respiratory syndrome coronavirus (MERS-CoV) has been confirmed by Public Health England (PHE) on the 23 August. Health authorities are identifying close contacts of the patient as a precautionary measure. This is the fifth case of MERS-CoV diagnosed in England, where there have been no cases since 2013.
Epidemiological update - Increase in Echovirus 30 detections in Denmark, the Netherlands, Norway and Sweden, July 2018
Since the beginning of the year, certain EU/EEA public health institutes have observed an upsurge in the number of positive enterovirus detections, especially Echovirus 30 (E30) cases. Norway  and the Netherlands  have published a report from national public health institutes on the increased E30 detections.
Preventing blood-borne viruses in prison settings: ECDC and EMCDDA Guidance
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.